RBC Life Sciences, Inc. (RBCL)
OTCMKTS
· Delayed Price · Currency is USD
0.0006
+0.0002 (50.00%)
At close: Jan 16, 2026
RBC Life Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | 2009 - 2005 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '15 Sep 30, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | 2009 - 2005 |
| Revenue | 24.12 | 28.27 | 25.47 | 25.16 | 28.45 | 28.16 | Upgrade
|
| Revenue Growth (YoY) | -12.49% | 10.99% | 1.23% | -11.56% | 1.03% | 12.97% | Upgrade
|
| Cost of Revenue | 10.39 | 12.63 | 13.46 | 12.53 | 14.13 | 14.47 | Upgrade
|
| Gross Profit | 13.72 | 15.64 | 12.01 | 12.63 | 14.32 | 13.69 | Upgrade
|
| Selling, General & Admin | 15.59 | 15.76 | 12.13 | 13.02 | 13.95 | 12.17 | Upgrade
|
| Operating Expenses | 16.04 | 16.26 | 12.64 | 13.54 | 14.39 | 12.64 | Upgrade
|
| Operating Income | -2.32 | -0.63 | -0.62 | -0.91 | -0.07 | 1.04 | Upgrade
|
| Interest Expense | -0.06 | -0.1 | -0.11 | -0.13 | -0.14 | -0.15 | Upgrade
|
| EBT Excluding Unusual Items | -2.38 | -0.72 | -0.74 | -1.03 | -0.21 | 0.89 | Upgrade
|
| Pretax Income | -0.67 | -0.72 | -0.74 | -0.59 | -0.21 | 0.89 | Upgrade
|
| Income Tax Expense | -0.11 | -0.12 | -0.24 | -0.23 | -0.14 | 0.33 | Upgrade
|
| Net Income | -0.56 | -0.6 | -0.5 | -0.36 | -0.07 | 0.56 | Upgrade
|
| Net Income to Common | -0.56 | -0.6 | -0.5 | -0.36 | -0.07 | 0.56 | Upgrade
|
| Shares Outstanding (Basic) | 2 | 2 | 2 | 2 | 2 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 2 | 2 | 2 | 2 | 2 | 2 | Upgrade
|
| Shares Change (YoY) | 0.00% | -0.29% | -0.19% | - | -0.92% | 2.35% | Upgrade
|
| EPS (Basic) | -0.25 | -0.27 | -0.23 | -0.16 | -0.03 | 0.25 | Upgrade
|
| EPS (Diluted) | -0.25 | -0.27 | -0.23 | -0.16 | -0.03 | 0.20 | Upgrade
|
| Free Cash Flow | -3.29 | -1.68 | 0.03 | -0.36 | -0.23 | 0.38 | Upgrade
|
| Free Cash Flow Per Share | -1.49 | -0.76 | 0.01 | -0.16 | -0.10 | 0.17 | Upgrade
|
| Gross Margin | 56.90% | 55.32% | 47.16% | 50.21% | 50.32% | 48.60% | Upgrade
|
| Operating Margin | -9.60% | -2.21% | -2.45% | -3.60% | -0.25% | 3.71% | Upgrade
|
| Profit Margin | -2.32% | -2.13% | -1.96% | -1.44% | -0.25% | 1.98% | Upgrade
|
| Free Cash Flow Margin | -13.63% | -5.95% | 0.11% | -1.43% | -0.79% | 1.35% | Upgrade
|
| EBITDA | -1.79 | -0.05 | -0.04 | -0.32 | 0.44 | 1.58 | Upgrade
|
| EBITDA Margin | -7.44% | -0.16% | -0.14% | -1.28% | 1.53% | 5.62% | Upgrade
|
| D&A For EBITDA | 0.52 | 0.58 | 0.59 | 0.58 | 0.51 | 0.54 | Upgrade
|
| EBIT | -2.32 | -0.63 | -0.62 | -0.91 | -0.07 | 1.04 | Upgrade
|
| EBIT Margin | -9.60% | -2.21% | -2.45% | -3.60% | -0.25% | 3.71% | Upgrade
|
| Effective Tax Rate | - | - | - | - | - | 37.42% | Upgrade
|
| Advertising Expenses | - | 0.04 | 0.04 | 0.12 | 0.06 | 0.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.